In a robust move to ensure drug safety in Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) has launched the ‘NAFDAC Green Book,’ a comprehensive database containing information on 6,432 registered and certified pharmaceutical products available for sale and distribution. This initiative aims to empower the public with easy online access to verify the authenticity of drugs, marking a significant step in NAFDAC’s commitment to eradicating the proliferation of unwholesome pharmaceutical products.
Prof. Mojisola Adeyeye, the Director General of NAFDAC, announced the launch during a media parley, underscoring the agency’s dedication to ensuring the safety of pharmaceutical products consumed by the public. As part of this commitment, NAFDAC’s enforcement directorate conducted the destruction of 135 truckloads of fake, counterfeit, and spurious products, including damaged or expired items voluntarily submitted by stakeholders. The estimated street value of the destroyed products amounted to approximately N16 billion.
NAFDAC Green Book Access:
Starting from January next year, the ‘NAFDAC Green Book’ will be accessible to the public, enabling individuals to use their Android mobile phones for easy verification of any drug of their choice.
Transparency and Consumer Safety:
The introduction of the database is a strategic move to enhance transparency and promote consumer safety within the pharmaceutical sector.
Achievements and Updates:
-
- Adeyeye shared the recent prequalification of the Central Drug Control Laboratory (CDCL) in Yaba, Lagos State, by the World Health Organisation. Constructed by NAFDAC for N4.5 billion, the laboratory is a crucial milestone in the nation’s pursuit of drug safety and increased local manufacturing capacity.
- The agency’s relentless efforts in combating the sale of adulterated pharmaceutical products were highlighted. The Investigation and Enforcement Directorate conducted joint inspection, seizure, and destruction exercises across various states.
- Adeyeye attributed the surge in counterfeit drugs to the challenging economic climate, fostering the production and sale of substandard products. However, she expressed optimism about Nigeria’s achievements, citing a 35% local manufacturing capacity for essential drugs.
- Despite challenges in digitalizing processes, NAFDAC is actively seeking assistance from developed countries to enhance its capabilities in this regard.
Future Plans:
NAFDAC plans to phase out the production and sale of alcohol in sachets by January 2024. Acknowledging the need for increased staffing and ongoing training initiatives, NAFDAC remains resolute in maintaining high standards and safeguarding public health.
The ‘NAFDAC Green Book’ serves as a crucial tool in the fight against counterfeit drugs, aligning with NAFDAC’s commitment to upholding pharmaceutical standards and ensuring the well-being of the Nigerian populace.
